Neurogene NGNE
NASDAQ NGNE
$25.50 -1.05 (-3.95%)
As of: Oct 2, 2026 · 3:18 PM EDT

Neurogene (NGNE) Accumulated Depreciation (2013 - 2018)

Updated

Neurogene's Accumulated Depreciation was $443,000 in Q4 2018, down 17.2% from $535,000 a year earlier.

Analysis

Neurogene (NGNE) Accumulated Depreciation (2013 - 2018) Analysis & Trends

From Q4 2013 onward, Neurogene has reported Accumulated Depreciation for 6 quarters.

  • Accumulated Depreciation shows a five-year compound annual growth rate of 11.9% (FY2013 to FY2018).
  • In earlier years, Accumulated Depreciation was $535,000 in FY2017 (+205.7%), $175,000 in FY2016 (+94.4%), $90,000 in FY2015 (-67.5%) and $277,000 in FY2014 (+9.6%).
  • The Q4 2018 figure marks the lowest quarterly Accumulated Depreciation since Q4 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Neurogene 627.40 Mn 627.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 443,000.00
Dec 31, 2017 535,000.00
Dec 31, 2016 175,000.00
Dec 31, 2015 90,000.00
Dec 31, 2014 277,000.00
Dec 31, 2013 252,729.00
API Access

Neurogene Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=NGNE&period=max&api_key=YOUR_API_KEY